Three innovative studies at AACR IO 2026 presented new ways for CAR T cells and antibody-lectin chimeras to tackle...
When runners cross the starting line at the AACR Rock ‘n’ Roll Philadelphia races later this month, several will...
This week, some of the world’s leading cancer researchers are gathering in Mainz/Frankfurt, Germany for the Third International Cancer...
This week’s excitement surrounding the groundbreaking U.S. Food and Drug Administration (FDA) approval of the CAR T–cell therapy tisagenlecleucel...
Yesterday marked a much anticipated milestone for the oncology community: The U.S. Food and Drug Administration (FDA) announced the...
A pair of studies published recently in journals of the American Association for Cancer Research bring to our attention...
Earlier this year, a study published in Cancer Discovery, a journal of the American Association for Cancer Research (AACR),...
A major objective of former Vice President Joe Biden’s National Cancer Moonshot Initiative is breaking down silos and sharing...
This week, the U.S. Food and Drug Administration (FDA) added two new treatments to the armamentarium for hematologic oncologists...
Patient enrollment in clinical trials has long been on the minds of oncologists and researchers. In 1990, fewer than...
As we learned recently, Senator John McCain was diagnosed with glioblastoma multiforme, an aggressive form of central nervous system...